Tigermed Announces Completion of Share Buyback Program, Repurchasing Over 20 Million A-Shares

Stock News07-02 22:32

Tigermed (HKG: 03347) has issued an announcement regarding the progress of its share repurchase initiative.

As of June 30, 2026, the company has repurchased a total of 20,963,500 A-shares through a dedicated securities account using centralized competitive bidding.

These repurchased shares represent approximately 2.4347% of the company's current total share capital and about 2.8410% of its total A-share capital.

The highest price paid per share was 42.78 yuan, while the lowest price was 38.22 yuan.

The total expenditure for the buyback amounted to 824 million yuan, excluding transaction fees.

The company stated that this share repurchase has been conducted in full compliance with its approved buyback plan and all relevant laws and regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1119405594?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 22:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119405594","market":"other","top_or_hot":-1,"title":"Tigermed Announces Completion of Share Buyback Program, Repurchasing Over 20 Million A-Shares","media":"Stock News","content":"<p><b>Tigermed</b> (<b>HKG: 03347</b>) has issued an announcement regarding the progress of its share repurchase initiative.<br><br>As of June 30, 2026, the company has repurchased a total of 20,963,500 A-shares through a dedicated securities account using centralized competitive bidding.<br><br>These repurchased shares represent approximately 2.4347% of the company's current total share capital and about 2.8410% of its total A-share capital.<br><br>The highest price paid per share was 42.78 yuan, while the lowest price was 38.22 yuan.<br><br>The total expenditure for the buyback amounted to 824 million yuan, excluding transaction fees.<br><br>The company stated that this share repurchase has been conducted in full compliance with its approved buyback plan and all relevant laws and regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tigermed Announces Completion of Share Buyback Program, Repurchasing Over 20 Million A-Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTigermed Announces Completion of Share Buyback Program, Repurchasing Over 20 Million A-Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-02 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Tigermed</b> (<b>HKG: 03347</b>) has issued an announcement regarding the progress of its share repurchase initiative.<br><br>As of June 30, 2026, the company has repurchased a total of 20,963,500 A-shares through a dedicated securities account using centralized competitive bidding.<br><br>These repurchased shares represent approximately 2.4347% of the company's current total share capital and about 2.8410% of its total A-share capital.<br><br>The highest price paid per share was 42.78 yuan, while the lowest price was 38.22 yuan.<br><br>The total expenditure for the buyback amounted to 824 million yuan, excluding transaction fees.<br><br>The company stated that this share repurchase has been conducted in full compliance with its approved buyback plan and all relevant laws and regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0077","symbol_name":"质押式回购","start_time":0,"source_url":"","article_id":"1119405594","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119405594","pubTimestamp":1783002771,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Tigermed (HKG: 03347) has issued an announcement regarding the progress of its share repurchase initiative.As of June 30, 2026, the company has repurchased a total of 20,963,500 A-shares through a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159982":"中证500","300347":"泰格医药","399300":"沪深300","BK0077":"质押式回购","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","03347":"泰格医药","BK1583":"高瓴概念","BK1141":"生命科学工具和服务","BK0028":"国家队","BK1576":"医药外包概念","BK0216":"研究试验","BK0174":"增持","LU1146622755.USD":"安本中国A股股票基金A Acc"},"translate_title":"泰格医药宣布完成股份回购计划回购超2000万股A股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159982":1,"300347":1,"399300":1,"03347":1},"content_text":"Tigermed (HKG: 03347) has issued an announcement regarding the progress of its share repurchase initiative.As of June 30, 2026, the company has repurchased a total of 20,963,500 A-shares through a dedicated securities account using centralized competitive bidding.These repurchased shares represent approximately 2.4347% of the company's current total share capital and about 2.8410% of its total A-share capital.The highest price paid per share was 42.78 yuan, while the lowest price was 38.22 yuan.The total expenditure for the buyback amounted to 824 million yuan, excluding transaction fees.The company stated that this share repurchase has been conducted in full compliance with its approved buyback plan and all relevant laws and regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1119405594","isCrawlerRequest":true}